10-95042980-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_000770.3(CYP2C8):c.1059C>T(p.His353His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00553 in 1,614,018 control chromosomes in the GnomAD database, including 202 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0037 ( 11 hom., cov: 32)
Exomes 𝑓: 0.0057 ( 191 hom. )
Consequence
CYP2C8
NM_000770.3 synonymous
NM_000770.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.775
Publications
8 publications found
Genes affected
CYP2C8 (HGNC:2622): (cytochrome P450 family 2 subfamily C member 8) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, benzo(a)pyrene, 7-ethyoxycoumarin, and the anti-cancer drug taxol. This gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 10-95042980-G-A is Benign according to our data. Variant chr10-95042980-G-A is described in ClinVar as [Benign]. Clinvar id is 775289.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.775 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0037 (564/152270) while in subpopulation SAS AF = 0.0498 (240/4822). AF 95% confidence interval is 0.0446. There are 11 homozygotes in GnomAd4. There are 332 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP2C8 | NM_000770.3 | c.1059C>T | p.His353His | synonymous_variant | Exon 7 of 9 | ENST00000371270.6 | NP_000761.3 | |
CYP2C8 | NM_001198853.1 | c.849C>T | p.His283His | synonymous_variant | Exon 7 of 9 | NP_001185782.1 | ||
CYP2C8 | NM_001198855.1 | c.849C>T | p.His283His | synonymous_variant | Exon 8 of 10 | NP_001185784.1 | ||
CYP2C8 | NM_001198854.1 | c.753C>T | p.His251His | synonymous_variant | Exon 6 of 8 | NP_001185783.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00369 AC: 562AN: 152152Hom.: 11 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
562
AN:
152152
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00882 AC: 2217AN: 251478 AF XY: 0.0113 show subpopulations
GnomAD2 exomes
AF:
AC:
2217
AN:
251478
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00572 AC: 8355AN: 1461748Hom.: 191 Cov.: 32 AF XY: 0.00734 AC XY: 5334AN XY: 727176 show subpopulations
GnomAD4 exome
AF:
AC:
8355
AN:
1461748
Hom.:
Cov.:
32
AF XY:
AC XY:
5334
AN XY:
727176
show subpopulations
African (AFR)
AF:
AC:
15
AN:
33474
American (AMR)
AF:
AC:
88
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
461
AN:
26134
East Asian (EAS)
AF:
AC:
10
AN:
39698
South Asian (SAS)
AF:
AC:
4334
AN:
86256
European-Finnish (FIN)
AF:
AC:
6
AN:
53420
Middle Eastern (MID)
AF:
AC:
146
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
2823
AN:
1111888
Other (OTH)
AF:
AC:
472
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
471
943
1414
1886
2357
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00370 AC: 564AN: 152270Hom.: 11 Cov.: 32 AF XY: 0.00446 AC XY: 332AN XY: 74442 show subpopulations
GnomAD4 genome
AF:
AC:
564
AN:
152270
Hom.:
Cov.:
32
AF XY:
AC XY:
332
AN XY:
74442
show subpopulations
African (AFR)
AF:
AC:
21
AN:
41548
American (AMR)
AF:
AC:
30
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
62
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
240
AN:
4822
European-Finnish (FIN)
AF:
AC:
1
AN:
10600
Middle Eastern (MID)
AF:
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
AC:
190
AN:
68022
Other (OTH)
AF:
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
24
48
72
96
120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
65
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 16, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.